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Phosphorylation and Increased Na Transport in Cortical
Collecting Duct Cells
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Aldosterone plays a central role in Na homeostasis by controlling Na reabsorption in the aldosterone-sensitive distal
nephron involving the epithelial Na channel (ENaC). Part of the effects of aldosterone is mediated by serum and glucocor-
ticoid-induced kinase 1 (Sgk1), a Ser/Thr kinase whose expression is rapidly induced by aldosterone and that increases in
heterologous expression systems ENaC cell surface abundance and activity. Previous work in Xenopus laevis oocytes
suggested that Sgk1 phosphorylates specific residues (Ser212 and Ser328) on the ubiquitin-protein ligase Nedd4-2, an enzyme
that directly interacts with ENaC and negatively controls channel density at the plasma membrane. It further indicated that
phosphorylation of Nedd4-2 led to impairment of ENaC/Nedd4-2 interaction and consequently to more channels at the cell
surface. These data suggested a novel mode of aldosterone-dependent action, yet this was not demonstrated formally in
epithelial cells that physiologically express ENaC. Here it is shown, with the use of an anti–phospho-Ser328-mNedd4-2
antibody, that 2 to 6 h of aldosterone treatment induces an increase in Nedd4-2 phosphorylation, both in a mouse cortical
collecting duct cell line (mpkCCDcl4) and in kidneys of adrenalectomized rats. This augmentation, which is accompanied by
a raise in Sgk1 expression and transepithelial Na transport, is sensitive to phosphatidylinositol-3 kinase inhibition, as is
Sgk1 phosphorylation and Na transport. Hence, these data provide evidence in cortical collecting duct cells in vitro and in
vivo that Sgk1-dependent phosphorylation of Nedd4-2 is part of the aldosterone response.
I n the aldosterone-sensitive distal nephron (1), aldosteronecontrols transepithelial Na and K transport, conse-quently regulating whole-body Na and K balance,
blood volume, and arterial BP (2). The hormone is known to
interact with the mineralocorticoid receptor, which, upon bind-
ing, translocates to the nucleus, where it orchestrates transcrip-
tional regulation of many different genes (2). The effect of
aldosterone on transepithelial Na transport has been well
described. After approximately 45 min, one observes an early
response, during which Na transport increases and the trans-
epithelial electrical resistance decreases. This is followed by a
late response, in which Na transport rate further increases,
without change of the epithelial resistance. The late response
shows an increase of the transcriptional/translational rate of
the two principal membrane complexes involved in Na trans-
port, the apical epithelial Na channel (ENaC) and the baso-
lateral Na,K-ATPase. The early response depends on the
action of early induced or repressed proteins (3). A number of
such proteins have been described, including K-Ras2A (3),
GILZ (4), and the serum and glucocorticoid-induced kinase 1
(Sgk1) (5,6). The last is a Ser/Thr kinase, originally identified as
a glucocorticoid-induced mRNA in mammary epithelial cells
(7). Cell volume control, regulation of apoptosis, stress re-
sponses, and activation of K channels are among the cellular
functions affected by Sgk1 (for a recent review see reference 8).
It shares strong homology with protein kinase B/Akt kinases
and is highly conserved in all eukaryotes. It is itself a phospho-
protein constituent of the phosphatidylinositol-3 kinase (PI-3K)
signaling cascade positioned downstream of PDK-1 (9). Sgk1
fulfills a number of properties of an early aldosterone-induced
regulator of transepithelial Na transport: (1) Its expression
increases shortly before the increase in Na transport (6,5,10),
(2) it stimulates transepithelial Na current in epithelial cells
(11–13), (3) its expression is elevated in adrenalectomized rats
upon acute administration of aldosterone in the cortical collect-
ing duct (CCD) with low circulating levels of aldosterone and
correlates with a decrease in urinary Na concentrations (10),
and (4) an Sgk1 mouse knockout model displays a salt-depen-
dent pseudohypoaldosteronism type I phenotype (14). The con-
sensus motif for phosphorylation by Sgk1 is RXRXXS/T (15,16),
a motif also present on the ubiquitin-protein ligase Nedd4-2.
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Nedd4-2, which is composed of a calcium-dependent lipid
binding domains C2, three to four WW protein:protein inter-
action domains, and the catalytic HECT domain (17), negatively
controls ENaC cell surface expression (18). We and others have
shown in Xenopus laevis oocytes that Sgk1 regulates ENaC by
phosphorylating Nedd4-2. Such phosphorylation decreases the
interaction between ENaC and Nedd4-2 interaction and leads
to the accumulation of functional ENaC channels at the cell
surface (19,20). It was postulated that this mechanism contrib-
utes to the aldosterone response. According to this working
model, aldosterone stimulates the expression of Sgk1, which
will increase the phosphorylation level of Nedd4-2 primarily on
Ser328 but also on Ser212, leading as in the oocytes to increased
density of ENaC at the apical membrane. However, to date, the
mode of Sgk1-dependent phosphorylation of Nedd4-2, as seen
in the oocytes, has not been demonstrated in renal epithelial
cells in vitro or in vivo.
Here we show, using a phospho-Nedd4-2–specific antibody,
that aldosterone induces phosphorylation of Nedd4-2 in vivo
and in an epithelial cell line derived from the mouse CCD
(mpkCCDcl4) (21). The increased phosphorylation level of
Nedd4-2 correlates with elevated Sgk1 expression and an in-
crease in transepithelial Na transport.
Materials and Methods
Plasmids and cDNA Constructs
cDNA constructs, encoding mouse Nedd4-2 and Xenopus laevis Sgk1,
the latter harboring a myc tag cDNA, both cloned into pSDeasy have
been described previously (17,19). Wild-type mNedd4-2 and mNedd4-
2-S328A (AF277232; 338 to 2905 bp) were cloned into the pAdTrack-
CMV shuttle vector (22). Mouse Nedd4-2 cDNA, lacking the C2 domain
and mutated on Ser328 or not, was cloned into the Epstein-Barr virus–
based retroviral vector (LZRS) (23).
Materials
Culture medium was from Invitrogen (San Diego, CA). Hormones
and reagents were from Sigma (St. Louis, MO). Tissue culture–treated
Transwell filters were from Corning Costar Corp. (Corning, NY).
Cell Culture
Experiments were carried out in the mpkCCDc14 cell line, a clone of
principal cells that has been derived from microdissected CCD of an
SV-PK/Tag transgenic mouse (21). The ecotropic retrovirus producer
Phoenix (nx) cell line was grown in DMEM that contained 10% FCS
with 100 U/l penicillin and 100 g/l streptomycin at 37°C/5% CO2.
Both cell lines were maintained and cultured as described previously
(23).
Expression in Xenopus Oocyte and Phosphorylation Assay
pSDeasy mNedd4-2 and Xenopus laevis Sgk1 constructs were tran-
scribed; the cRNA was injected into Xenopus oocytes; and after over-
night incubation, lysates were prepared as described previously (19).
For characterizing the anti–p328S-Nedd4-2 antibody, lysates were
treated with 1/10 vol of 2 M Tris/HCl (pH 9.0) with or without calf
intestinal alkaline phosphatase (CIP; Roche, Rotkreuz, Switzerland)
and incubated for 3 h at 37°C. The enzyme was inactivated by adding
5 SDS-PAGE sample buffer and heating for 5 min at 95°C. Immuno-
blots were prepared and analyzed with anti–p-S328-Nedd4-2, anti-myc,
and anti–Nedd4-2 antibodies as described previously (19,24).
Retroviral Infection of mpkCCDcl4 Cells
Retroviruses encoding LZRS–mNedd4-2 that were prepared in Phoe-
nix (nx) retrovirus producer cells were used to infect mpkCCDcl4 cells
as described previously (23).
Adenovirus Production
mNedd4-2 and mNedd4-2S328A were cloned into the pAdTrack-
CMV shuttle vector. The constructs were linearized with PmeI and
transformed into Escherichia coli BJ5183-AD-1 electroporation compe-
tent cells (Stratagene, La Jolla, CA). From transformation on, adenovi-
ruses were produced according to the manufacturer’s protocol (Ad-
EasyXL Adenoviral Vector System; Stratagene).
Short-Circuit Current Measurements
Transepithelial short circuit currents (Isc) were recorded on mpkCCDcl4
cells that were grown on collagen-coated Transwell filters mounted in a
modified Ussing chamber (25) as described previously (23). Briefly, cell
layers were bathed in symmetrical solutions (120 mM NaCl, 5 mM KCl, 25
mM NaHCO3, 1 mM Na-pyruvate, 0.9 mM Na-phosphate, 10 mM d-
glucose, 1 mM MgCl2, and 1.8 mM CaCl2) and gassed continuously with
O2/CO2 95%/5% to keep the pH at 7.4 in the presence or absence of 10M
amiloride. Isc was measured by clamping the open-circuit PD to 0 mV. The
amiloride-sensitive Isc was calculated, and values were normalized against
control amiloride-sensitive Isc.
Antibodies
The anti–Nedd4-2 phosphopeptide antibody was raised in rabbits using a
keyhole limpet hemocyanin-coupled, synthetic phosphopeptide (KPRSL-
SPhos-SPTV), affinity-purified on the corresponding phospho- and non-phos-
phopeptide and used as described previously (24). For the peptide competi-
tion assay (Figure 1B), the antibodies first were incubated overnight at 4°C
with 20 g/ml of either phopho- or dephosphopeptide. An antibody against
Nedd4-2 was raised in rabbits against a GST fusion protein that comprised
mouse Nedd4-2 amino acids 201 to 260 (GEQFSSLIQREPSSRLRSCSVTDT-
VAEQAHLPPPSTPTGRARSSTVTGGEESTPSVAY). For immunofluores-
cence experiments, it was affinity-purified by passing it over a GST column,
followed by binding and elution on a GST–mNedd4-2 (201 to 260) column,
according to standard techniques. Anti-Sgk and anti-actin antibodies were
from Sigma. Anti–enhanced green fluorescent protein (JL-18 living colors)
was from Clontech (Palo Alto, CA).
Immunofluorescence in Kidneys of Rats
Kidneys of adrenalectomized (ADX) male Wistar rats (body weights
180 to 200 g) were taken from a previous experiment (1) in which rats
received either a single injection of vehicle or 50 g/kg body wt
aldosterone. The experiments were performed in accordance with the
Guide for the Care and Use of Laboratory Animals (Institute of Labo-
ratory Animal Resources, National Academy of Sciences, Bethesda,
MD). The kidneys had been fixed by vascular perfusion with 3%
paraformaldehyde and 0.05% picric acid as described (1) and had been
stored at 80°C until use. Cryosections (5 m thick) of kidneys from
three vehicle-treated rats and three rats with an aldosterone injection
2 h before being killed were incubated overnight at 4°C with either
affinity-purified anti–Nedd4-2 phosphopeptide antibody (dilution 1:50)
or affinity-purified anti–Nedd4-2 antibody (dilution 1:200). Binding
sites of the primary antibodies were detected with a Cy3-conjugated
goat anti-rabbit IgG (Jackson ImmunoResearch Labs, West Grove, PA)
diluted 1:1000. In some experiments, the primary anti–Nedd4-2 phos-
phopeptide antibody was preincubated overnight at 4°C with the im-
munogenic phosphopeptide (20 g/ml) or its nonphosphorylated
counterpart (20 g/ml). For histologic analysis, the slides were studied
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by two investigators who were blinded to the treatment of the rats. The
staining intensities with the two Nedd4-2 antibodies were rated for
each rat on a scale from 1 to 5, with 1 for the lowest and 5 for the highest
staining intensities. According to these ratings, the kidney samples
were ranked from weak to high staining intensities. These qualitative
rankings were confirmed further by digital image analysis. For each rat
(three vehicle-treated ADX rats and three aldosterone-treated rats), at
least four micrographs of randomly selected CCD profiles were ac-
quired by using a charge-coupled device camera. Camera settings were
kept constant for each image. The mean pixel intensity for the collecting
duct epithelia were determined with the NIH Image software (National
Institutes of Health, Bethesda, MD).
Biochemical Analysis in CCD Cell Lines
Differentiated mpkCCDcl4 monolayers or 293 cells were lysed in lysis
buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 1.5 mM MgCl2, 1 mM
EGTA, 10% glycerol, and 1% Triton X-100) that contained protease
inhibitors (1 mM PMSF, 10 g/ml leupeptin, 10 g/ml pepstatin A,
and 10 g/ml aprotinin) and phosphatase inhibitors (100 mM NaF, 10
mM Na-pyrophosphate, and 10 mM Na-orthovanadate). This lysate
was centrifuged (20,000  g, 4°C, 15 min), and the supernatant was
recovered. Samples were analyzed by SDS-PAGE/Western blotting as
indicated. Briefly, samples were run on 8% SDS-PAGE gels and trans-
ferred on nitrocellulose. Blots were blocked in blocking buffer (1 PBS,
0.05% Triton X-100, 0.02% Na-azide, and 5% nonfat dry milk) for 30 min
and incubated with primary antibody for 1 h in the same solution.
Excess primary antibody was removed by four washes with Wash
buffer (1 PBS and 0.05% Triton X-100) plus 3% skim milk and exposed
to secondary antibody coupled to horseradish peroxidase (Amersham)
during 30 min. After four washes with Wash buffer, blots were devel-
oped either with the ECL Western Blotting Detection (Amersham,
Otelfingen, Switzerland) or with the SuperSignal West Dura Kit (Pierce,
Rockford, IL) and exposed to Biomax XAR films (Kodak, Rochester,
NY). Quantification of recognized levels was performed on these flu-
orograms using a molecular imager FX (Biorad, Hercules, CA), and the
results were normalized to the controls and expressed as mean  SEM.
Statistical analyses were performed using the unpaired two-tailed t test.
For Figure 2D, lysates were mixed with one tenth of their volume with
shrimp alkaline phosphatase (Roche; 10 reaction buffer and 28 l of
shrimp alkaline phosphatase) and incubated for 30 min at 37°C. SDS-
PAGE sample buffer (5) was added, and samples were boiled at 95°C
for 5 min. Immunoblots were as described above.
Analysis of Sgk1 Phosphorylation by Phosphatase Treatment
Cells that were treated or not with 1 M aldosterone for 3 h were
lysed in lysis buffer that contained phosphatase inhibitors or not (100
mM NaF, 10 mM Na-pyrophosphate, and 10 mM Na-orthovanadate; as
indicated in the Figure 3). Samples were treated with Lambda protein
phosphatase (10 U/l; New England Biolabs, Beverly, MA) during 30
min at 30°C. Reactions were stopped by adding SDS-PAGE sample
buffer and boiling at 95°C for 5 min. Samples were analyzed by SDS-
PAGE/Western blotting using anti-Sgk antibody.
Statistical Analyses
Data are presented as means of normalized values  SEM. The
difference between means was analyzed by the two-tailed t test for
unpaired data.
Results
Specificity of Anti–pSer328-Nedd4-2 Antibody
Recently we showed in Xenopus laevis oocytes that Sgk1
phosphorylates Xenopus laevis Nedd4-2 primarily on Ser444
Figure 1. Characterization of an antibody against a phos-
phopeptide covering mNedd4-2 serine 328. (A) Xenopus laevis
oocytes were injected with cRNA encoding mNedd4-2 or myc-
xSgk1 as indicated. After 24 h, lysates were prepared, treated or
not with calf intestinal phosphatase ( or  calf intestinal
alkaline phosphatase), and analyzed by SDS-PAGE/Western
blotting with anti–pSer328-Nedd4-2 and anti-myc (top) and
anti–Nedd4-2 (bottom). (B) Oocytes expressing Sgk1 and
Nedd4-2 (as indicated) were analyzed by Western blotting,
using anti–pNedd4-2 antibodies that were incubated overnight
with excess of phospho- (ppept) or dephosphopeptide (de-
ppept). (C) Western blotting analysis of 293 cells that were
infected for 24 h with adenovirus encoding mNedd4-2 and
enhanced green fluorescence protein (eGFP), mNedd4-2S328A
and eGFP, or eGFP alone. Lysates were blotted with anti–
phospho-Nedd4-2, anti–Nedd4-2, anti-GFP (to monitor infec-
tion efficiency), and anti-actin antibodies. *Endogenous cross-
reacting protein, likely endogenous Nedd4-2.
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(corresponding to Ser328 in mouse Nedd4-2) (19). To study the
phosphorylation of mouse Nedd4-2 (mNedd4-2) on Ser328 in
epithelial cells, we raised and purified a phosphopeptide anti-
body against this region (anti–pS328-Nedd4-2) as described
previously (24). Although the antibody was characterized to-
ward human Nedd4-2, we confirmed its specificity for phos-
phorylated mouse Nedd4-2 by three means. First, we expressed
Nedd4-2 with or without Sgk1 in Xenopus laevis oocytes and
carried out Western blot analysis using anti–pSer328-Nedd4-2
(Figure 1A, top). Consistent with our previous observation that
in oocytes Nedd4-2 is phosphorylated in the presence of Sgk1
(19), we detected mNedd4-2 only when mNedd4-2 and Sgk1
Figure 2. Effect of aldosterone and phosphatidylinositol-3 kinase (PI-3K) inhibition on transepithelial Na transport, Sgk1 expression,
and phosphorylation of S328–Nedd4-2. (A) Mouse cortical collecting duct (CCD) cells (mpkCCDcl4) grown on collagen-coated filters
were stimulated for the indicated times with 1 M aldosterone (aldo). When indicated, 50 M of LY-294002 (LY) was added to inhibit
PI-3K activity 30min before electrophysiologic measurements of the cells. Amiloride-sensitive short-circuit currents weremeasured and
normalized to the currents of nonstimulated cells (n  9 to 12 filters from three independent experiments). *P  0.05 versus control;
***P 0.005 versus nonstimulated cells. (B) mpkCCDcl4 cells were treated with 1 M aldosterone (aldo) for the indicated times and/or
30 min of 50 M LY-294002 before lysis. Lysates then were analyzed by SDS-PAGE/Western blot, using anti–pS328-mNedd4-2,
mNedd4-2, Sgk, and actin antibodies. (C) p-mNedd4-2Ser328 andmNedd4-2 bands on fluorograms (of B) were quantified, and the ratio
of pS328–mNedd4-2 to mNedd4-2 was calculated and normalized to the control condition (n 4 to 7 independent experiments). *P
0.05 versus control. (D) Western blotting of lysates of mpkCCDcl4 monolayers prepared in lysis buffer that contained or did not contain
phosphatase inhibitors, using the indicated antibodies. (E) mpkCCDcl4 cells transduced with a retrovirus encoding mNedd4-2 or
noninfected control cells were treated or not treated for 3 h with 1 M aldosterone. Lysates were analyzed as described in B.
Endogenous Nedd4-2 is indicated by arrows; exogenous Nedd4-2 is shown by arrowheads. * in B, D, and E denotes a cross-reacting,
endogenous protein, likely an alternatively spliced Nedd4-2 isoform.
4
ht
tp
://
do
c.
re
ro
.c
h
were coexpressed (Figure 1A, lane 3, top). When the lysate was
treated with calf-intestinal phosphatase (calf intestinal alkaline
phosphatase, lanes 4 to 6) or when Sgk1 was omitted (lanes 2
and 5), no band was observed despite the presence of Nedd4-2,
as shown with another non–phosphoform-specific anti–
Nedd4-2 antibody (Figure 1A, bottom). Second, in a competi-
tion assay, the anti–pSer328-Nedd4-2 antibody was incubated
overnight with excess mNedd4-2 phospho- (ppept) or dephos-
phopeptide (de-ppept), and Western blot analysis of oocytes
that were injected or not with mNedd4-2xSgk1 was per-
formed. The signal disappears only in the presence of the
phosphopeptide, further corroborating the specificity of the
anti–pSer328-Nedd4-2 antibody (Figure 1B). Finally, we in-
fected 293 cells with an adenovirus encoding either mNedd4-2
or mNedd4-2-S328A (Ser328 mutated to alanine). As shown in
Figure 1C, anti–pSer328-Nedd4-2 recognized only mNedd4-2
but not mNedd4-2-S328A, further demonstrating the specificity
for p-S328–mNedd4-2.
Aldosterone Stimulates Transepithelial Na Currents, Sgk1
Expression, and Nedd4-2 Phosphorylation in a PI-3K–
Dependent Manner
Having established the specificity of anti–p-mNedd4-2S328,
we tested whether aldosterone augmented Nedd4-2 phosphor-
ylation on Ser328 in renal epithelial cells. To carry out these
studies, we took advantage of the mpkCCDcl4 cell line, a highly
differentiated cell model, derived from the mouse CCD and
displaying aldosterone-dependent transepithelial Na trans-
port (21). mpkCCDcl4 monolayers that were grown on collagen-
coated filters were treated with 1 M aldosterone for 30 min
and 3 h. Because it was shown previously in A6 cells that the
PI-3K inhibitor LY-294002 inhibits the aldosterone response
(26), we tested the effect of 50 M of LY-294002 on a subset of
filters 30 min before the measurements. Amiloride-sensitive
short-circuit current, representing Na currents via ENaC, was
measured in a modified Ussing chamber and normalized to
control currents (i.e., to the mean currents of untreated cells of
the same day; Figure 2A). In agreement with previous reports
(27), a 3-h aldosterone treatment significantly stimulated Na
currents. When LY-294002 was added, the basal and 30-min
aldosterone currents were reduced by approximately 30%. Af-
ter 3 h of aldosterone treatment, LY-294002 inhibited most of
the current increase, indicating that the aldosterone early re-
sponse depends on PI-3K activity (as reported previously for
A6 cells [26]).
To evaluate the effect of aldosterone and LY-294002 on Sgk1
expression and Nedd4-2 phosphorylation, we analyzed cell
lysates by SDS-PAGE/Western blotting, using antibodies
against Sgk, pS328–Nedd4-2, Nedd4-2, or actin (Figure 2B). As
reported previously (27), 3 h of aldosterone treatment stimu-
lated the expression of Sgk1 kinase, displaying several bands
on the Western blot (Figure 2B, third panel). To corroborate that
the slower migrating protein bands represented differentially
phosphorylated Sgk1, we treated the lysate with -phosphatase
and found that these bands were disappearing, whereas treat-
ment with phosphatase inhibitors increased the intensity of
these bands. Moreover, without aldosterone treatment, none of
the Sgk1 forms was detectable (Figure 3). Concomitant with the
expression of Sgk1, the level of pS328–Nedd4-2 also increased
(Figure 2B, top), whereas the total amount of Nedd4-2 re-
mained unchanged. Quantification of the protein bands of four
to seven independent experiments and calculation of the
p-Nedd4-2 to Nedd4-2 ratio revealed a 1.8-fold increase of
phospho Nedd4-2 as compared with the control (Figure 2C).
Importantly, in contrast to the situation in Xenopus oocytes (19),
Nedd4-2 seemed to be phosphorylated on Ser328 even in the
absence of any detectable Sgk1 (i.e., under control condition or
30 min of aldosterone stimulation). The notion that this band at
basal conditions indeed represents phosphorylated Nedd4-2 is
supported by the finding that incubation of cell lysates without
phosphatase inhibitors for 30 min at 30°C leads to its near-
complete disappearance when probed with anti–pS328-
Nedd4-2 antibodies (Figure 2D, top).
When cells were treated with LY-294002, the slower migrat-
ing bands of Sgk1 became weaker (consistent with PI-3K–
dependent phosphorylation of Sgk1), and the global expression
levels of Sgk1 decreased (Figure 2B, third right panel). In par-
allel, the increase of phosphorylated Nedd4-2 with 3 h of aldo-
sterone treatment was completely prevented by the PI-3K in-
hibitor (Figure 2B, top right panel; quantification in Figure 2C).
Notably, the basal phosphorylation level of Nedd4-2 observed
in the control and with 30 min of aldosterone treatment per-
sisted with the PI-3K inhibitor.
To confirm further that aldosterone induces the phosphory-
lation of Nedd4-2, we expressed an exogenous mNedd4-2 pro-
tein in mpkCCDcl4 cells, using a retroviral vector. This protein,
which lacks the C2 domain, migrates faster than endogenous
Nedd4-2 and therefore can be identified simultaneously by
anti–Nedd4-2 antibodies. Nedd4-2C2 was found to be ex-
pressed properly, although at lower levels than the endogenous
proteins (Figure 2E, bottom). Under basal conditions, the en-
dogenous Nedd4-2 was phosphorylated, whereas the exog-
enously expressed Nedd4-2C2 protein was not detectable
with the anti–pS328-Nedd4-2 antibody (Figure 2E, top). When
cells were stimulated with aldosterone, phosphorylation levels
of both endogenous and exogenous Nedd4-2 increased, sup-
Figure 3. Dephosphorylation of Sgk1 by phosphatase treatment
in mpkCCDcl4 lysate. Cells that treated or not with 1 M
aldosterone for 3 h were lysed in lysis buffer that contained
phosphatase inhibitors or not (as indicated). Samples were
treated with Lambda protein phosphatase during 30 min at
30°C, and reactions were stopped by adding SDS-PAGE sample
buffer and boiling at 95°C for 5 min. Samples were analyzed by
SDS-PAGE/Western blotting using anti-Sgk antibody.
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porting the notion that aldosterone controls phosphorylation
levels of Nedd4-2.
Sgk1 Expression Precedes Increase in Nedd4-2
Phosphorylation
Because it has been suggested that Sgk1 is involved in S328–
Nedd4-2 phosphorylation (19), we were interested to know
whether such phosphorylation follows Sgk1 expression. We
carried out a time course of aldosterone treatment over 6 h
(Figure 4). mpkCCDcl4 lysates were collected and analyzed by
Western blotting for Sgk1 and Nedd4-2 expression, as well as
phosphorylation level of Nedd4-2 Ser238. Sgk1 became detect-
able after 1 h of aldosterone induction and reached a peak at 3 h
(Figure 4A, third panel). This was followed by an increase in
S328–Nedd4-2 phosphorylation (Figure 4A, top, and quantifi-
cation in Figure 4B), compatible with the notion that Sgk1 is
involved in Nedd4-2 phosphorylation.
Aldosterone Increases Phosphorylation of mNedd4-2
in the CCD
Having established that aldosterone is able to stimulate Sgk1
expression and Nedd4-2 phosphorylation in mpkCCDcl4 cells,
we wished to know whether aldosterone increases the level of
phosphorylation in the CCD in vivo, as well. To address this
question, we carried out immunohistochemistry on kidneys
from adrenalectomized rats with and without aldosterone
treatment. First, we tested the usefulness and the specificity of
the anti–p328-Nedd4-2 antibody for immunohistochemical
studies. On kidney sections from intact rats, the anti–p328-
Nedd4-2 antibody (Figure 5A) strongly labeled the cytoplasm
of epithelial cells lining the collecting ducts as shown for med-
ullary collecting duct profiles in Figure 5A. Weak staining was
also seen in other tubules such as thick ascending limbs (Figure
5A) and proximal tubules in the renal cortex (data not shown).
Preincubation of the anti–p328-Nedd4-2 antibody with the im-
munogenic phosphopeptide completely abolished the immu-
nostaining, whereas preincubation with the nonphosphopep-
tide was without any effect on the staining qualities of the
antibody, indicating that the antibody recognizes only Nedd4-2
phosphorylated at position 328. Previous studies on ADX rats
Figure 4. Time-dependent effect of aldosterone effect on S328–
mNedd4-2 phosphorylation in mpkCCDcl4. (A) Cells were
treated with 1 M aldosterone for the indicated times. Lysates
were prepared and analyzed by Western blotting with anti–
p-mNedd4-2Ser328, mNedd4-2, Sgk1, or actin antibodies. *En-
dogenous cross-reacting band. (B) pS328–mNedd4 and
mNedd4-2 bands on fluorograms (A) were quantified using a
phosphoimager, and the ratio of p-mNedd4-2Ser328 to
mNedd4-2 was calculated and normalized to control condition.
**P  0.01 versus nonstimulated cells (t  0).
Figure 5. In vivo phosphorylation of S328–mNedd4-2 in cryo-
sections of rat kidneys. (A) Inner stripe of outer kidney medulla
immunostained with anti–pS328-mNedd4-2 antibodies (left)
and with anti–p-mNedd4-2Ser328 antibodies that were prein-
cubated with the immunogenic phosphopeptide (middle) or
the corresponding dephosphopeptide (right). *Collecting ducts.
(B) Kidney cortex immunostained with anti–p-mNedd4-2-
Ser328 or mNedd4-2 antibodies. Two hours after a single aldo-
sterone injection, p-mNedd4-2–Ser328 immunostaining is in-
creased in the cytoplasm of CCD cells, whereas mNedd4-2–
related immunostaining is unaffected by the aldosterone
application.
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showed that aldosterone increases Sgk1 expression from very
low levels to high levels within 2 h and causes a redistribution
of ENaC from the cytoplasm to the apical plasma membrane
within 4 h (1). Now, we used the same tissues (from the
experiments done for reference 1) to assess the phosphorylation
status of Nedd4-2 in collecting ducts of vehicle- and aldoste-
rone-treated ADX rats (Figure 5B). We found that pS328–
Nedd4-2 was easily detectable in the collecting ducts of vehicle-
treated ADX rats (in the absence of any aldosterone). However,
2 h after aldosterone injection, the p328–Nedd4-2–related im-
munostaining was clearly enhanced (Figure 5B, top). In con-
trast, the signal, obtained with an antibody that recognized
both phosphorylated and unphosphorylated Nedd4-2, did not
differ between collecting ducts from vehicle- and aldosterone-
treated ADX rats (Figure 5B, bottom). Qualitative rating and
digital image analysis of the staining intensities for each anti-
body and each rat (see the Materials and Methods section)
confirmed these observations. For pNedd4-2 but not for
Nedd4-2, all control rats were ranked below the aldosterone-
treated rats. Measured mean pixel intensities for pNedd4-2
were consistently lower in the three vehicle-treated ADX rats
(12.9, 13.8, and 19.6 arbitrary units; mean values per rat) than in
the three aldosterone-treated ADX rats (21.2, 25.9, and 33.9
arbitrary units; mean values per rat). In contrast, measured
values for Nedd4-2 did not clearly differ between vehicle-
treated ADX rats (15.5, 19.0, and 26.7 arbitrary units) and
aldosterone-treated rats (16.9, 19.5, and 37.3 arbitrary units).
Taken together, these data indicate that aldosterone rapidly
increases the level of phosphorylation on Ser328 of Nedd4-2 in
the CCD in vivo, whereas it does not change the total pool of
Nedd4-2, at least within the time frame of 2 h.
Discussion
In this study, using the mpkCCDcl4 cell line and ADX rats,
we studied Sgk1 expression and correlated it with transepithe-
lial Na transport and S328–Nedd4-2 phosphorylation levels.
We took advantage of a specific antibody raised against a
phosphopeptide covering mNedd4-2 Ser328 (24), which we
further characterized with respect to its specificity for phos-
phorylated mouse Nedd4-2.
Our data demonstrate that in mpkCCDcl4 cells and in vivo in
ADX rats, aldosterone stimulates the expression of Sgk1 and
the phosphorylation of Ser328 of Nedd4-2 by approximately
1.8-fold. This increase in Nedd4-2–S328 phosphorylation is ac-
companied by the appearance of Sgk1 and by an increase of
transepithelial, amiloride-sensitive Na transport (Figure 2A).
Moreover, when a time course of aldosterone stimulation is
carried out, Sgk1 expression precedes slightly Nedd4-2 phos-
phorylation, but both peak at approximately 3 h of stimulation.
When cells were treated with the PI-3K inhibitor LY-294002, the
aldosterone-dependent increase of Na transport and Nedd4-2
phosphorylation were inhibited, consistent with previous re-
ports showing that PI-3K activity is required for mineralocor-
ticoid-dependent Na response (12,26,28) and for activation of
Sgk1 (9,16). However, PI-3K inhibition reduces basal Na
transport but not basal phosphorylation levels of Nedd4-2. This
suggests that a kinase different from Sgk1, Sgk2, Sgk3, or
protein kinase B/Akt (all PI-3K dependant) is responsible for
basal phosphorylation. One possible candidate is protein kinase
A, as proposed recently by Snyder et al. (29), who have shown
that the same residue can be phosphorylated by protein kinase
A. Inhibition of PI-3K activity consistently resulted in a weak-
ening of slower migrating Sgk1 bands (most likely phosphor-
ylated forms of Sgk1) and also in a reduction of the total pool
of Sgk1 (Figure 2B). Similar observations were made previously
in A6 cells by Wang et al. (26), who observed a slight, statisti-
cally nonsignificant decrease of total Sgk1 expression. There-
fore, expression of Sgk1 may depend on PI-3K activity.
It is interesting that the data in Figure 2E suggest that basal
phosphorylation of Nedd4-2 requires the C2 domain, as the
exogenous Nedd4-2 lacking the C2 domain does not display
any basal phosphorylation. The C2 domain is a Ca2-depen-
dent phospholipid-binding domain that has been shown to
influence localization of the Nedd4-2 paralogue Nedd4–1
(30,31) or Nedd4-2 (32) and to interfere with Nedd4–1–depen-
dent regulation of ENaC in Xenopus laevis oocytes (33,34). It
therefore is conceivable that deletion of the C2 domain may
change the properties or the localization of Nedd4-2 in
mpkCCDcl4 cells, consequently interfering with the basal
phosphorylation by a kinase other than Sgk1.
It now is well established that Sgk1 is an early aldosterone-
induced protein that seems to regulate ENaC and control Na
reabsorption (1,10–13). In support of our previous work (19),
we now provide evidence that aldosterone regulates Na trans-
port in CCD cells via phosphorylation of Nedd4-2. Such phos-
phorylation then leads to interference with the ENaC/Nedd4-2
interaction, most likely because the phosphorylated Ser238
serves as a binding site for 14-3-3 adaptor proteins, which may
sterically hinder the binding of Nedd4-2 to ENaC (35). The
change in phosphorylation of Nedd4-2 is modest (approxi-
mately two-fold), as compared with the more than seven-fold
stimulation of the Na currents, indicating that the early re-
sponse of aldosterone action involves not only Nedd4-2 phos-
phorylation. Clearly other factors also play a role in aldoste-
rone-controlled Na transport. Not only ENaC activity is
affected by aldosterone but also the Na,K-ATPase (36),
which has been shown to be regulated by Sgk1 as well (37).
Moreover, there are several consensus phosphorylation sites for
Sgk1 on Nedd4-2, which may as well be modified by changing
levels of Sgk1 (19,20). Alternatively, Sgk1 may act, in addition
to Nedd4-2 phosphorylation, via different mechanisms, such as
direct binding and phosphorylation of ENaC, as suggested
previously (26,38). Such additional mechanisms, which would
preserve the sensitivity of aldosterone stimulation to PI-3K
inhibition, are compatible with reports showing that Sgk1 in-
creases ENaC activity in oocytes even when the PY motifs on
ENaC (binding sites for Nedd4-2) are missing (39,40) or that
aldosterone increases the activity of channels missing either the
- or -subunit PY motif in mpkCCDcl4 cells (23) or transgenic
mice (41).
In conclusion, our data demonstrate that aldosterone in-
creases Nedd4-2 phosphorylation, simultaneously with Sgk1
expression, both in CCD cells derived from the mouse kidney
and in vivo in ADX rats. This supports a model in which
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aldosterone increases Sgk1 expression, which then will phos-
phorylate Nedd4-2. Such phosphorylation has been shown to
interfere with ENaC/Nedd4-2 interaction, consequently reduc-
ing Nedd4-2–dependent ENaC ubiquitinylation, internaliza-
tion and leading to accumulation of ENaC channels at the
plasma membrane.
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